Clinical trial
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
NCT00092001 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00092001 |
|---|---|
| Title | Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer |
| Official title | A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Sunitinib |
| Enrollment | 111 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 27, 2004 |
| Last update posted | Oct 16, 2008 |
| Countries | Italy, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: